Dublin, March 05, 2025 (GLOBE NEWSWIRE) — The “Microcarriers Market by Product (Equipment (Single Use Bioreactor, SSB, Cell Counter, Filtration), Consumables (Media, Reagent), Beads (Natural (Collagen), Synthetic (Polystyrene)), Application (Vaccine, CGT, Stem Cells) – Global Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering.
The global microcarriers market is projected to reach USD 3.05 billion by 2029 from USD 2.08 billion in 2024, at a CAGR of 8% during the forecast period of 2024 to 2029.
The factors contributing to the growth of the microcarriers market are rising investments in cell & gene therapy research, technological advancement in in microcarrier-based cell production and increasing applications of microcarrier in vaccines and therapeutics development. Furthermore, limitations in high-density cell culture and high cost of research and development are the factors expected to hinder the market growth over the forecast period.
The pharmaceutical and biotechnology companies segment accounted for the largest share by end user in 2023
Based on end user, the microcarriers market is segmented into pharmaceutical & biotechnology companies, academic and research institutes, contract research organizations & contract manufacturing organizations, and cell banks. The pharmaceutical & biotechnology companies segment accounted for the largest share of the microcarriers market in 2023.
The larger share of this segment is mainly attributed to the growing regulatory approvals for cell-based vaccines, increased adoption of single-use bioprocessing products, recent developments in 3D cell culture, increased production of monoclonal antibodies (mAbs), and growing awareness of the advantages of cell-based vaccines.
The US will continue to dominate the microcarriers market during the forecast period of 2024-2032
The US leads the globe in biopharmaceutical research and investment, and it has the biggest biopharmaceutical market in the world. The need for safe and high-quality products in the healthcare industry, the growing number of patients with chronic diseases, the growing significance of biopharmaceuticals, and the rising investments and funding in biomedical research by government agencies and pharmaceutical and biotechnology companies are all driving factor for US market.
Another important element fostering market expansion is the region’s well-established presence of a number of industry participants. Among these important businesses are Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), and Corning Incorporated (US).
Research Coverage
This research report categorizes the gene therapy market by Product, Application, End User and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the microcarriers market.
A detailed analysis of the key industry players has been done to provide insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. New approvals/launches, collaborations and acquisitions, and recent developments associated with the microcarriers market.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 558 |
| Forecast Period | 2024-2029 |
| Estimated Market Value (USD) in 2024 | $2.08 Billion |
| Forecasted Market Value (USD) by 2029 | $3.05 Billion |
| Compound Annual Growth Rate | 8% |
| Regions Covered | Global |
Market Dynamics
- Drivers
- Increasing Demand for Cell-based Vaccines
- Rising Technological Advancements in Microcarrier-based Cell Production Tools
- Growing Investments in Cell & Gene Therapy Research
- Rising Preference for Single-Use Technologies
- Increasing R&D Spending for Biopharmaceutical Production
- Restraints
- High Cost of Cell Biology Research
- Limitations in High-Density Cell Culture Production
- Opportunities
- Growing Demand for 3D Cell Culture
- Increasing Demand for Monoclonal Antibodies and Biosimilars
- Growth Potential in Emerging Economies
- Challenges
- High Costs Associated with Serum-Free Media
- Complex Microcarrier Cell Detachment Process
Additional insights covered include:
- Trends/Disruptions Impacting Customer Business
- Pricing Analysis
- Value Chain Analysis
- Supply Chain Analysis
- Ecosystem Analysis
- Investment/Funding Activity
- Technological Analysis
- Patent Analysis
- Trade Analysis
- Key Conferences and Events, 2025-2026
- Regulatory Landscape
- Key Stakeholders and Buying Criteria
- Impact of AI on Microcarriers Market
Companies Profiled
- Thermo Fisher Scientific Inc.
- Sartorius AG
- Danaher Corporation
- Merck KGaA
- Corning Incorporated
- Fujifilm Holdings Corporation
- BD
- Eppendorf SE
- Lonza
- Getinge AB
- Entegris
- Bio-Rad Laboratories, Inc.
- Kuraray Co. Ltd.
- Teijin Limited
- Asahi Kasei Corporation
- Cellevate AB
- PBS Biotech, Inc.
- Solida Biotech GmbH
- Reprocell Inc.
- G&G Technologies, Inc.
- Denovomatrix GmbH
- Bio-Link
- BBI-Biotech GmbH
- Smart MCS Pty. Ltd.
- Bionet
For more information about this report visit https://www.researchandmarkets.com/r/up8hdj
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
